You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

broadly neutralizing antibody

Showing 1 - 25 of 7,696
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)

Not yet recruiting
  • Human Immunodeficiency Virus
  • New York, New York
  • +2 more
Jul 12, 2022

Hiv Trial in Denmark, United Kingdom (Romidepsin, 3BNC117, Antiretrovirals)

Active, not recruiting
  • Hiv
  • Aalborg, Denmark
  • +6 more
Sep 3, 2021

HIV Trial in Bangkok (VRC01, Placebo for VRC01)

Completed
Has Results
  • HIV Infections
  • VRC01
  • Placebo for VRC01
  • Bangkok, Thailand
    SEARCH Thai Red Cross AIDS Research Centre Non-Network CRS
Oct 29, 2021

Broadly HIV-1 Neutralizing Antibodies in HIV-infected Mbeya,

Active, not recruiting
  • HIV/AIDS
    • Mbeya, Tanzania
      NIMR-Mbeya Medical Research Center (MMRC)
    Aug 5, 2022

    COVID-19 Trial in Beijing (SA55 nasal spray)

    Recruiting
    • COVID-19
    • SA55 nasal spray
    • Beijing, Chaoyang, China
      Beijing Ditan Hospital Capital Medical University
    Sep 15, 2023

    HIV Trial in Philadelphia (3BNC117-LS, 10-1074-LS)

    Suspended
    • HIV Infections
    • Birmingham, Alabama
    • +5 more
    Jan 31, 2023

    HIV Trial in Worldwide (VRC01, Placebo for VRC01)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • Placebo for VRC01
    • Gaborone, South-East District, Botswana
    • +20 more
    Feb 8, 2022

    SARS-CoV-2, Prevention Trial in Chongqing (MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray, Placebo Comparator: MY-586

    Recruiting
    • SARS-CoV-2
    • Prevention
    • MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray
    • Placebo Comparator: MY-586 SARS-CoV-2 Neutralization Antibody nasal excipient
    • Chongqing, Chongqing, China
      The Second Affiliated Hospital of Chongqing Medical University
    Aug 2, 2023

    HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

    Not yet recruiting
    • HIV-1-infection
    • VRC07-523LS
    • +7 more
    • Pathum Wan, Bangkok, Thailand
    • +1 more
    Mar 8, 2023

    HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

    Not yet recruiting
    • HIV-1-infection
    • ChAdOx1.tHIVconsv1
    • +7 more
    • San Diego, California
    • +11 more
    Oct 4, 2023

    HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

    Not yet recruiting
    • HIV Infections
    • Teropavimab
    • +4 more
    • (no location specified)
    Feb 6, 2023

    HIV Trial in Worldwide (GSK3810109A)

    Active, not recruiting
    • HIV Infections
    • GSK3810109A
    • Long Beach, California
    • +24 more
    Nov 30, 2022

    HIV Infection Trial in United States (N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074)

    Recruiting
    • HIV Infection
    • N-803 (IL-15 Superagonist)
    • +2 more
    • Los Angeles, California
    • +11 more
    Sep 22, 2022

    Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)

    Not yet recruiting
    • Hepatitis b Virus
    • HepB mAb19
    • Sterile Saline
    • New York, New York
    • +1 more
    May 12, 2023

    AAV9 Neutralizing Antibody Seroconversion in Household Contacts.

    Recruiting
    • Household Contacts
    • Blood Draw
    • Baltimore, Maryland
      Kennedy Krieger Institute
    Oct 4, 2022

    HIV Trial in Worldwide (VRC01, Placebo for VRC01)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • Placebo for VRC01
    • Birmingham, Alabama
    • +25 more
    Feb 8, 2022

    Tetanus Trial in China (TNM002 (low dose), TNM002 (medium dose), TNM002 (high dose))

    Completed
    • Tetanus
    • TNM002 (low dose)
    • +4 more
    • Shantou, Guangdong, China
    • +3 more
    Nov 20, 2022

    HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)

    Unknown status
    • HIV
    • +2 more
    • Pegylated Interferon alpha 2b (peg-IFN-α2b)
    • 3BNC117 + 10-1074
    • Philadelphia, Pennsylvania
    • +1 more
    Jun 22, 2021

    COVID-19 Pandemic Trial in Macau (Bacillus subtilis spore extract)

    Completed
    • COVID-19 Pandemic
    • Bacillus subtilis spore extract
    • Macau, Macau
      Macao Greater Bay Area Association of Healthcare Providers
    Jun 24, 2022

    Neutralizing Antibody Level After COVID-19 Vaccination

    Recruiting
    • Covid19
    • COVID-19 neutralizing antibody
    • Daegu, Korea, Republic of
      Kyungpook National University Hospital
    Oct 18, 2021

    Cancer Trial in New Taipei City (solid organ malignancies treatment)

    Recruiting
    • Cancer
    • solid organ malignancies treatment
    • New Taipei City, Taiwan
      TuCheng Hospital
    May 18, 2022

    HIV, AIDS, Immunologic Deficiency Syndrome, Acquired Trial in Boston (Ad26.Mos4.HIV, MVA-BN-HIV, PGT121)

    Recruiting
    • HIV
    • +4 more
    • Ad26.Mos4.HIV
    • +4 more
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Apr 18, 2022

    SARS-COV-2/COVID-19 Neutralizing Antibodies in Blood

    Completed
    • SARS-CoV2 Infection
      • Starkville, Mississippi
      • +4 more
      Aug 8, 2022

      SARS-CoV-2, Prevention Trial in Chongqing (A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray, A8G6 SARS-CoV-2

      Recruiting
      • SARS-CoV-2
      • Prevention
      • A8G6 SARS-CoV-2 Neutralization Antibody combination nasal spray
      • A8G6 SARS-CoV-2 Neutralization Antibody nasal excipient
      • Chongqing, Chongqing, China
        The Second Affiliated Hospital of Chongqing Medical University
      Nov 9, 2023

      Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)

      Not yet recruiting
      • Acute HIV Infection
      • VRC07-523LS
      • +3 more
      • Birmingham, Alabama
      • +35 more
      Jan 30, 2023